Work

Phase 1/2 clinical trial of JIN-A02, a 4th generation EGFR-TKI in EGFR-mutated advanced/metastatic non-small cell lung cancer.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.tps8650

Authors: Sun Min Lim, Byoung Chul Cho, Ji-Youn Han, Sang-We Kim, Ki Hyeong Lee, Byoung Yong Shim, Jong-Mu Sun, Misako Nagasaka, Anna Jo, Ethan Seah, Choonok Kim, Thanyanan Reungwetwattana

Institutions: Yonsei University, Yonsei Cancer Hospital, National Cancer Center, Asan Medical Center, University of Ulsan, Chungbuk National University, Chungbuk National University Hospital, The Catholic University of Korea St. Vincent's Hospital, Samsung Medical Center, University of California, Irvine, UC Irvine Chao Family Comprehensive Cancer Center, J Ints Bio (South Korea), Mahidol University, Ramathibodi Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410804562

Cites:

Cited by:

Related to: 10